hematopoietic system
N |
• mutants injected with pIpC to induce expression of Cre recombinase exhibit normal myeloid cell development, neutrophil counts, hemoglobin levels, and maintenance of hematopoietic stem cells in adults
|
• pIpC treated mutants exhibit an increase in apoptosis of myeloid colony-forming cells
|
• pIpC treated mutants exhibit a significant block in the maturation of T-cell progenitors at the transition from CD44+CD25+ (double negative 2) to CD44-CD25+ (double negative 3), indicating the accumulation of immature T-cell precursors in the thymus
|
• the immature megakaryocytes observed in bone marrow of mutants injected with pIpC exhibit poorly demarcated membranes and a lower level of polyploidy than controls
|
• after injection of pIpC to induce expression of Cre recombinase, bone marrow exhibits an arrest in megakaryocytic maturation
|
• after injection of pIpC to induce expression of Cre recombinase, mutants exhibit an increase in hematopoietic progenitor cells
• bone marrow cells from pIpC injected mutants form more megakaryocytic (CFU-Meg), myeloid, and mixed (myeloid and erythroid) colonies in vitro than control bone marrow cells
|
• immediately after injection of pIpC to induce expression of Cre recombinase, mice show a decline in platelet counts to 1/3 to 1/6 of those for the control
|
immune system
• pIpC treated mutants exhibit a significant block in the maturation of T-cell progenitors at the transition from CD44+CD25+ (double negative 2) to CD44-CD25+ (double negative 3), indicating the accumulation of immature T-cell precursors in the thymus
|
cellular
• after injection of pIpC to induce expression of Cre recombinase, bone marrow exhibits an arrest in megakaryocytic maturation
|